IHE holdings

All 57 positions of iShares U.S. Pharmaceuticals ETF.

Download CSV

Positions

Top 10 weight

79.2%

Effective holdings

8.1

1 / sum of squared weights

In stocks

99.9%

In bonds

0.0%

Outside the US

0.0%

Asset mix

Equity99.9%
Cash0.1%

Sectors

100% of stocks classified

Health Care99.8%
Technology0.1%

Countries

United States99.9%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	LLYEli Lilly & Co.	Equity	24.14%	$370M	316,126	US
2	JNJJohnson & Johnson	Equity	22.28%	$341M	1,330,676	US
3	PFEPfizer Inc.	Equity	4.65%	$71M	2,558,639	US
4	ZTSZOETIS INC.	Equity	4.63%	$71M	969,564	US
5	VTRSViatris Inc. Common Stock	Equity	4.55%	$70M	3,998,032	US
6	MRKMerck & Co., Inc.	Equity	4.48%	$69M	481,797	US
7	RPRXRoyalty Pharma plc Class A Ordinary Shares	Equity	4.30%	$66M	1,173,121	US
8	BMYBristol-Myers Squibb Co.	Equity	4.29%	$66M	1,103,539	US
9	JAZZJazz Pharmaceuticals, Inc.	Equity	3.28%	$50M	225,955	US
10	CORTCorcept Therapeutics Inc.	Equity	2.56%	$39M	331,119	US
11	ELANElanco Animal Health Incorporated Common Stock	Equity	2.56%	$39M	1,739,092	US
12	AXSMAxsome Therapeutics, Inc	Equity	1.72%	$26M	154,978	US
13	LGNDLigand Pharmaceuticals Inc.	Equity	1.34%	$20M	69,391	US
14	DFTXDefinium Therapeutics, Inc. Common Shares	Equity	1.04%	$16M	467,703	US
15	INDVIndivior Pharmaceuticals, Inc. Common Stock	Equity	0.95%	$15M	410,787	US
16	MANEVeradermics, Incorporated	Equity	0.90%	$14M	109,069	US
17	AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	Equity	0.82%	$13M	642,544	US
18	OGNOrganon & Co.	Equity	0.82%	$13M	914,089	US
19	EWTXEdgewise Therapeutics, Inc. Common Stock	Equity	0.73%	$11M	283,516	US
20	AMLXAmylyx Pharmaceuticals, Inc. Common Stock	Equity	0.64%	$9.7M	358,242	US
21	TARSTarsus Pharmaceuticals, Inc. Common Stock	Equity	0.63%	$9.7M	134,413	US
22	ELVNEnliven Therapeutics, Inc. Common Stock	Equity	0.59%	$9.0M	221,884	US
23	SUPNSupernus Pharmaceuticals, Inc.	Equity	0.56%	$8.5M	202,343	US
24	PBHPrestige Consumer Healthcare Inc.	Equity	0.52%	$7.9M	164,957	US
25	LQDALiquidia Corporation Common Stock	Equity	0.47%	$7.2M	258,601	US
26	PRGOPERRIGO COMPANY PLC	Equity	0.46%	$7.0M	483,310	US
27	HRMYHarmony Biosciences Holdings, Inc. Common Stock	Equity	0.45%	$6.8M	172,380	US
28	XERSXeris Biopharma Holdings, Inc. Common Stock	Equity	0.42%	$6.5M	635,322	US
29	MBXMBX Biosciences, Inc. Common Stock	Equity	0.36%	$5.5M	104,006	US
30	TRVITrevi Therapeutics, Inc. Common Stock	Equity	0.35%	$5.3M	416,920	US
31	INVAInnoviva, Inc. Common Stock	Equity	0.34%	$5.3M	251,566	US
32	ANIPANI Pharmaceuticals, Inc.	Equity	0.33%	$5.1M	70,201	US
33	PCRXPacira BioSciences, Inc. Common Stock	Equity	0.33%	$5.0M	138,507	US
34	OCULOcular Therapeutix, Inc.	Equity	0.32%	$4.8M	642,597	US
35	OMEROmeros Corporation	Equity	0.31%	$4.8M	251,537	US
36	NUVBNuvation Bio Inc.	Equity	0.30%	$4.5M	917,660	US
37	RAPPRapport Therapeutics, Inc. Common Stock	Equity	0.24%	$3.6M	122,096	US
38	HROWHarrow, Inc. Common Stock	Equity	0.22%	$3.4M	110,725	US
39	MAZEMaze Therapeutics, Inc. Common Stock	Equity	0.22%	$3.3M	127,392	US
40	SEPNSepterna, Inc. Common Stock	Equity	0.20%	$3.1M	82,867	US
41	LBRXLB Pharmaceuticals Inc Common Stock	Equity	0.20%	$3.0M	87,632	US
42	AMPHAmphastar Pharmaceuticals, Inc.	Equity	0.18%	$2.8M	109,376	US
43	PAHCPhibro Animal Health Corporation Class A	Equity	0.18%	$2.7M	73,212	US
44	COLLCollegium Pharmaceutical, Inc. Common Stock	Equity	0.16%	$2.5M	113,123	US
45	ALMSAlumis Inc. Common Stock	Equity	0.14%	$2.2M	314,821	US
46	WVEWave Life Sciences Ltd. Ordinary Shares	Equity	0.12%	$1.8M	520,360	US
47	CRMDCorMedix Inc.	Equity	0.11%	$1.7M	230,204	US
48	EOLSEvolus, Inc. Common Stock	Equity	0.10%	$1.6M	204,260	US
49	AVLNAvalyn Pharma Inc. Common Stock	Equity	0.10%	$1.6M	61,615	US
50	ARVNArvinas, Inc	Equity	0.10%	$1.6M	209,029	US
51	PHATPhathom Pharmaceuticals, Inc. Common Stock	Equity	0.09%	$1.4M	202,398	US
52	EYPTEyePoint, Inc. Common Stock	Equity	0.07%	$1.0M	299,571	US
53	USDProShares Ultra Semiconductors	Cash	0.07%	$1.0M	1,016,448	US
54	BIOABioAge Labs, Inc. Common Stock	Equity	0.05%	$842K	135,563	US
55	XTSLABLK CSH FND TREASURY SL AGENCY	Cash	0.02%	$265K	264,630	US
56	SGAFTCASH COLLATERAL USD SGAFT	Cash	0.01%	$95K	95,000	US
57	IXCZ6E-MINI HEALTH CARE SECTOR DEC 26	Derivative	0.00%	$0	9

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Exit	TERNTerns Pharmaceuticals Inc	1.27%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	DFTXDefinium Therapeutics Inc	0.52%	1.39%	+27.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ZTSZOETIS INC.	4.52%	3.73%	+61.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	PFEPFIZER INC.	4.71%	3.96%	+16.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	JNJJOHNSON & JOHNSON	23.03%	22.44%	+11.6%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	MANEVeradermics Inc	—	0.56%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	BMYBRISTOL-MYERS SQUIBB COMPANY	4.63%	4.37%	+18.2%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	ATAIAtaiBeckley Inc	—	0.23%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	TRVITrevi Therapeutics Inc	0.35%	0.50%	+10.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ELVNEnliven Therapeutics Inc	0.49%	0.63%	+18.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	LENZLENZ Therapeutics Inc	0.06%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	NKTRNEKTAR THERAPEUTICS	0.56%	0.54%	+17.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	MAZEMaze Therapeutics Inc	0.18%	0.19%	+29.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	INDIVIOR PLC	1.21%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	INDVINDIVIOR PHARMACEUTICALS, INC.	—	1.06%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	JNJJOHNSON & JOHNSON	22.01%	23.03%	−14.0%	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	AVDLAVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY	0.57%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	ALMSAlumis Inc	—	0.50%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	NKTRNEKTAR THERAPEUTICS	0.23%	0.56%	+37.5%	Dec 31, 2025 → Mar 31, 2026 SEC
New position	LBRXLB Pharmaceuticals Inc	—	0.17%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	VTYXVentyx Biosciences Inc	0.16%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	BIOABIOAGE Labs Inc	—	0.15%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	BMYBRISTOL-MYERS SQUIBB COMPANY	4.63%	4.63%	−13.6%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	MRKMERCK & CO., INC.	4.74%	4.74%	−15.0%	Dec 31, 2025 → Mar 31, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.